Marcie A. Goldstein

Davis Polk advised the joint book-running managers in connection with the $120 million follow-on offering of common stock of Global Blood Therapeutics, Inc. Global Blood’s common stock is…

Davis Polk advised the representative of the underwriters in connection with the $181 million public offering of 4,025,000 shares of common stock of Spark Therapeutics, Inc. (“Spark”),…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Bunge Finance Europe B.V., a wholly owned subsidiary of Bunge Limited, of €600million…

Davis Polk advised the representative of the underwriters in connection with the approximately $67 million SEC-registered offering of 7,500,000 shares of common stock of Ardmore Shipping…

Davis Polk advised the sole bookrunning manager in connection with the public offering of 3,500,000 shares of the common stock of Coherus BioSciences, Inc. at a price to the public of …

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $124.2 million SEC-registered offering of 6,555,000 shares of common stock…

Davis Polk advised the joint bookrunners and joint global coordinators of the several underwriters in connection with the international initial public offering by Grupo Supervielle S.A…

Davis Polk advised the joint book-running managers in connection with a $41.4 million SEC-registered common stock offering of 1,926,250 shares of common stock of Loxo Oncology, Inc…

Davis Polk advised the joint book-running managers in connection with a $115.1 million SEC-registered offering of 5,479,750 ordinary shares of Theravance Biopharma, Inc. The ordinary shares…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $531 million initial public offering by Red Rock Resorts Inc. of 27,250,000 shares…